Figure 2
Total daily heparin dose on all ECMO patients demonstrating no significant relationship to (A) APTT and a significant relationship to (B) Anti-FXa levels.
Figure 2 | Scientific Reports
Total daily heparin dose on all ECMO patients demonstrating no significant relationship to (A) APTT and a significant relationship to (B) Anti-FXa levels.
